Ki-ras mutations in adenomas: A characteristic of cancer-bearing colorectal mucosa

Journal of Pathology

Volumn 180, Issue 4, 1996, Pages 357-363

  Morris, Robert G ^a   Curtis, Lucy J ^a   Romanowski, Piotr ^b   Hardcastle, Jack D ^c   Jenkins, David A ^c   Robinson, Michael ^c   Wyllie, Andrew H ^a   Bird, Colin C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WELLCOME CRC INSTITUTE   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Adenomas colorectal; APC; Ki ras

Indexed keywords

ADULT; AGED; ARTICLE; COLON ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENES, APC; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 0030470733     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199612)180:4<357::AID-PATH710>3.0.CO;2-D     Document Type: Article

References (31)

1. McCormick F. Ras GTPase activating protein: signal transmitter and signal termination. Cell 1989; 56: 5-8.
2. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell function. Nature 1990; 348: 125-132.
3. Downward J. The ras superfamily of small GTP-binding proteins. TIBS 1990; 15: 469-472.
4. Marshall MS. The effector interactions of p21 (ras). TIBS 1993; 364: 352-355.
5. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancer. Nature 1987; 327: 293-297.
6. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of Ki-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298-303.
7. Bos JL. ras oncogenes in human colon cancer: a review. Cancer Res 1989; 49: 4682-4386.
8. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
9. Fearon ER, Vogelstein B. A genetic model of colorectal tumorigenesis. Cell 1990; 61: 759-767.
10. Scott N, Bell SM, Sagar P, Blair GE, Dixon MF, Quirke P. p53 expression and Ki-ras mutation in colorectal adenomas. Gut 1993; 34: 621-624.
11. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982; 49: 819-825.
12. Williams AR, Balasooriya BAW, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23: 835-842.
13. Morson BC, Bussey HJR. Predisposing causes of intestinal cancer. Curr Probl Surg 1970; Feb: 1-50.
14. Muto T, Bussey HJR, Morsen BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
15. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979; 43: 1847-2857.
16. Bolan CR. The biology of colorectal cancer: implications for pretreatment and follow-up management. Cancer 1993; 71: 4180-4186.
17. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992; 1: 229-233.
18. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-237.
19. Tsao J, Shibata D. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am J Pathol 1994; 145: 531-534.
20. Holgate CS, Jackson P, Pollard K, Lunny D, Bird CC. Effect of fixation on T and B lymphocyte surface membrane antigen demonstration in paraffin processed tissue. J Pathol 1986; 149: 293-300.
21. Hardcastle JD, Farrands PA, Balfour TW, Chamberlain J, Amar S, Sheldon MG. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 1983; 2: 1-4.
22. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer: results for the first 107,349 subjects. Lancet 1989; 1: 1160-1164.
23. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985; 130: 118-126.
24. Balfe P, Simmonds P, Ludlum CA, Bishop JO, Leigh Brown AJ. Concurrent evolution of human immunodeficiency virus type I in patients infected from the same course: rate of sequence change and low frequency of inactivating mutation. J Virol 1990; 6: 6221-6233.
25. Curtis L, Wyllie AH, Shaw JJ, et al. Evidence against involvement of APC mutation in papillary thyroid carcinoma. Eur J Cancer 1994; 30A: 984-987.
26. Cripps KJ, Purdie C, Carder PJ, et al. A study of stabilisation of p53 protein versus point mutation in colorectal cancer. Oncogene 1994; 9: 2739-2743.
27. Losi L, Benhattar J, Costa J. Stability of Ki-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 1992; 28A: 1115-1120.
28. Finkelstien SD, Sayegh R, Bakker A, Swalsky P. Determination of tumour aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 1993; 128: 526-532.
29. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location, Br J Cancer 1994; 69: 367-371.
30. Shibata D, Schaeffer J, Li ZH, Capella G, Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 1993; 85: 1058-1063.
31. Moerkerk P, Arends JW, van Driel M, de Bruine A, de Goeij A, ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994; 54: 3376-3378.